Sinil Pharmaceutical Co. Ltd (012790.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea · ISIN KR7012790002
Sinil Pharmaceutical Co. Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 89.44 bn KRW | 80.56 bn KRW |
| Gross profit | 40.67 bn KRW | 33.44 bn KRW |
| Operating income | 15.25 bn KRW | 7.39 bn KRW |
| EBIT | 16.56 bn KRW | 8.62 bn KRW |
| Net income | 14.30 bn KRW | 7.53 bn KRW |
| Diluted EPS – continuing operations | 1,237.13 KRW | 651.49 KRW |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sinil Pharmaceutical Co. Ltd
Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.
More stocks
- Hwacheon Machi (010660.KS)
- Hour Loop, Inc (HOUR)
- Daily Polymer (4716.TWO)
- Touchstone Exploration Inc (TXP.TO)
- Anfield Resources Inc (AEC.V)
- SEMICO CAPITAL BERHAD (0388.KL)
- Company K Partners Limited (307930.KQ)
- UPEXI, INC. (UPXI)
- Cardiff Oncology, Inc. (CRDF)
- ALUX Co., Ltd. (475580.KQ)
- Nordwest Handel AG (NWX.F)
- SYNergy ScienTech Corp (6558.TW)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.